Submitted:
12 August 2024
Posted:
13 August 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
2. Materials and Methods
- The RPIC activates the FTS using a mobile phone app (segregated from the GCS).
- The app sends the activation command through the mobile network to the FTS comms module installed on the aircraft (segregated from the C2 link and using a different network provider).
- The FTS comms module activates the FTS device. Once activated, the FTS reroutes the motor and servo inputs to be controlled by the auxiliary Flight Controller which is pre-programmed to:
- Stabilize and stop the aircraft in Hovering mode as quickly as possiblem(approx. 4G deceleration)
- Navigate to the horizontal GPS location where the FTS was triggered in Hovering mode at slow speed (5m/s),
- Turn into the wind using the weathervane function to let the Cruising motor help in countering the wind more efficiently,
- Slowly descend at 3m/s or less until touchdown,
- Disarm the aircraft.
3. Results
4. Discussion
5. Conclusions
Author Contributions
Acknowledgments
Conflicts of Interest
References
- Sigari, Cyrus, and Peter Biberthaler. "Medical drones: Disruptive technology makes the future happen." Der Unfallchirurg 124.12 (2021): 974.
- Zailani, Mohamed Afiq Hidayat, et al. "Drone for medical products transportation in maternal healthcare: A systematic review and framework for future research." Medicine 99.36 (2020): e21967.
- George, ANANYA ELIZABETH. "Employment of drones in medical, emergency and relief settings." International Journal of Research in Humanities, Arts and Science, 5 (1) (2017): 21-27.
- Wulfovich, Sharon, Homero Rivas, and Pedro Matabuena. "Drones in healthcare." Digital Health: Scaling Healthcare to the World (2018): 159-168.
- Oigbochie, A. E., E. B. Odigie, and B. I. G. Adejumo. "Importance of drones in healthcare delivery amid a pandemic: Current and generation next application." Open Journal of Medical Research (ISSN: 2734-2093) 2.1 (2021): 01-13.
- Yakushiji, Koki, et al. "Short-range transportation using unmanned aerial vehicles (UAVs) during disasters in Japan." Drones 4.4 (2020): 68.
- Konert, Anna, Jacek Smereka, and Lukasz Szarpak. "The use of drones in emergency medicine: practical and legal aspects." Emergency medicine international 2019.1 (2019): 3589792.
- Johnson, Anna M., et al. "Impact of using drones in emergency medicine: What does the future hold?." Open Access Emergency Medicine (2021): 487-498.
- Wolfe, Mary K., Noreen C. McDonald, and G. Mark Holmes. "Transportation barriers to health care in the United States: findings from the national health interview survey, 1997–2017." American journal of public health 110.6 (2020): 815-822.
- Weiss, D. J. , et al. "Global maps of travel time to healthcare facilities." Nature medicine 26.12 (2020): 1835-1838.
- Poljak, Mario, and A. J. C. M. Šterbenc. "Use of drones in clinical microbiology and infectious diseases: current status, challenges and barriers." Clinical Microbiology and Infection 26.4 (2020): 425-430.
- Demuyakor, John. "Ghana go digital Agenda: The impact of zipline drone technology on digital emergency health delivery in Ghana." Humanities 8.1 (2020): 242-253.
- Tarr, Anthony A., et al. "Drones—healthcare, humanitarian efforts and recreational use." Drone Law and Policy. Routledge, 2021. 35-54.
- González-Domínguez, Raúl, et al. "Recommendations and best practices for standardizing the pre-analytical processing of blood and urine samples in metabolomics." Metabolites 10.6 (2020): 229.
- Gerber, Teresa, et al. "Assessment of pre-analytical sample handling conditions for comprehensive liquid biopsy analysis." The Journal of Molecular Diagnostics 22.8 (2020): 1070-1086.
- Thuile, Katharina, et al. "Evaluation of the in vitro stability of direct oral anticoagulants in blood samples under different storage conditions." Scandinavian Journal of Clinical and Laboratory Investigation 81.6 (2021): 461-468.
- Amukele, T. K. , Sokoll, L. J., Pepper, D., Howard, D. P., & Street, J. (2017). Can unmanned aerial systems (drones) be used for the routine transport of chemistry, hematology, and coagulation laboratory specimens?. PLOS ONE, 12(7), e0180183.
- Rosser, J. C. , Vignesh, V., Terwilliger, B. A., & Parker, B. C. (2018). Surgical and medical applications of drones: a comprehensive review. JSLS: Journal of the Society of Laparoscopic & Robotic Surgeons, 22(3).
- Sharma, A. , Kwon, J., Ravichandran, N., & Park, S. (2019). Evaluation of blood sample transportation using small drones. Clinical Chemistry and Laboratory Medicine (CCLM), 57(12), 1778-1785.
- Amukele TK, Sokoll LJ, Pepper D, Howard DP, Street J (2015) Can Unmanned Aerial Systems (Drones) Be Used for the Routine Transport of Chemistry, Hematology, and Coagulation Laboratory Specimens? PLoS ONE 10(7): e0134020. [CrossRef]
- Roberts, Nathan B., et al. "Current summary of the evidence in drone-based emergency medical services care." Resuscitation Plus 13 (2023): 100347.
- Zailani, M. A. , et al. "Drone versus ambulance for blood products transportation: an economic evaluation study." BMC health services research 21 (2021): 1-10.
- Anand, R. , et al. "Emergency Medical Services Using Drone Operations in Natural Disaster and Pandemics." Inventive Communication and Computational Technologies: Proceedings of ICICCT 2021. Springer Singapore, 2022.
- Sivasuriyan, V. "Drone usage and disaster management." Bodhi Int. J. Res. Humanit. Arts Sci 5 (2021): 93-97.


| cruising | Horizontally | 35m on each side of the Flight Path. This accounts for inaccuracy of the navigation due to GPS imprecision or meteorological conditions and allows the aircraft to safely maneuver within the margins of error. |
| cruising | Vertically | 20m above the Flight Path -> 120m AGL |
| hovering | Horizontally | 10m on each side of the flight path. This accounts for the low speed of the aircraft. |
| hovering | Vertically | 10m above the Flight Path -> 40m AGL This accounts for the low speed of the aircraft. |
| cruising | Horizontally | 35m on each side of the Flight Geography. This conservatively allows the aircraft to automatically initiate the Flight Geography contingency procedure to stop and hover from a cruise speed of 30m/s (approx. 26m), considering a positioning inaccuracy of 4m and an extra margin of 5m. |
| cruising | Vertically | 20m above the Flight Geography -> 150m AGL assuming 1s of reaction time at 45 deg pitch up at 20m/s + 4m of GPS error |
| hovering | Horizontally | 10m on each side of the Flight Geography. This accounts for the low speed of the aircraft. |
| hovering | Vertically | 10m above the Flight Geography -> 50m AGL This accounts for the low speed of the aircraft and the flight mode. |
| Aircraft type | Unmanned electric aircraft, capable of vertical takeoff and landing (eVTOL) and fixed-wing flight. x |
| Dimensions | 35 x 290 x 240 cm [H x W x L] |
| Weight | 18 Kg empty incl. batteries |
| 21 Kg max. gross take-off weight (MGTOW) | |
| Propulsion | Hovering motors: 8x 150Kv motors with 22inch propellers (IP 45 rating) |
| Cruising motors: 2x 360Kv motors with 12inch propellers | |
| Avionics | 1x 64 Bit ARM 6 Cores, 6 MB L2 + 4 MB L3, 8 GB RAM, 128-Bit-LPDDR4x 59,7 GB/s |
| 1x 32 Bit ARM, 480MHz, 2MB memory, 512KB RAM | |
| 1x 32 Bit ARM, 24MHz, 8KB SRAM (3x Accelerometers/Gyros, 2x Barometers, 2x airspeed sensors, 1x GPS Module) | |
| 1x 32 Bit ARM, 480MHz, 2MB memory, 512KB RAM | |
| 1x 32 Bit ARM, 72MHz, 64KB SRAM (2x Accelerometers/Gyros, 2x Barometers, 1x GPS Module) | |
| Awareness systems | 1x downward-facing awareness systems |
| 2x forward-facing awareness systems | |
| 1x LiDAR ground altimeter: downward facing for long range | |
| Awareness radios | 1x ADS-B In |
| 1x FLARM in and out | |
| 1x remote ID, compliant with FAR Part 89 | |
| Connectivity (CON2) | 3x LTE SIM cards slots for three different providers |
| Flight modes | Multicopter mode and Fixed wing mode |
| Cruise Speed | 59 KIAS (30m/s) |
| Stall Speed (MGTOW) in Fixed Wing mode | 33 KIAS (17m/s) |
| Max Density Altitude | 2438m |
| Max Endurance | 118 minutes |
| Max Wind | 29 KTS (15m/s) |
| Max Precipitation | Light to moderate |
| Operating time | Day, Night (under dev) |
| Operating temperature | -20° to 50° C |
| Range | max 120km, 2min hovering, 3kg payload, 5m/s of head wind, ideal cruising speed, 200m AMSL, no altitude changes or curves, 10% reserve |
| Weather limitations | suitable for operation in coastal and offshore climate |
| no operation during heavy rain, icing conditions, hail, and thunderstorms | |
| Noise Emissions | While cruising at 60m above ground level: 58dB |
| Delivery methods | Mailbox docking on balcony or window (under development) |
| Ground landing | |
| Customer Privacy | The video transmitted to the pilot for landing is blurred at the source |
| The recorded flight data is deleted and overwritten after every flight |
| Bland-Altman | |||||||
| Analyte | Unit | n | Mean | Slope | r | Intercept | Arithmetic mean % |
| Alk. Phos. | U/L | 20 | 77.85 | 1.000 | 0.984 | 0.000 | -0.10 |
| Billirubin total | umol/L | 20 | 3.53 | 1.000 | 0.867 | 0.800 | -5.79 |
| Calcium | mmol/L | 20 | 2.41 | 1.000 | 0.934 | 0.000 | -0.05 |
| Cholesterol | mmol/L | 20 | 5.06 | 1.000 | 0.991 | 0.000 | -0.20 |
| Creatine kinase | U/L | 20 | 92.30 | 1.009 | 0.997 | -0.595 | -0.50 |
| CRP | mg/L | 20 | 4.04 | 1.010 | 0.997 | -0.413 | -0.40 |
| Protein total | g/L | 20 | 68.50 | 1.000 | 0.845 | 0.000 | -0.20 |
| Ferritin | ng/mL | 20 | 188.46 | 1.023 | 0.998 | -2.668 | -0.40 |
| Folate | nmol/L | 20 | 20.19 | 0.974 | 0.978 | 0.231 | 0.90 |
| ƴGT | U/L | 20 | 29.70 | 1.000 | 0.995 | 0.000 | -0.80 |
| Glucose | mmol/L | 20 | 5.71 | 1.000 | 0.989 | 0.000 | 0.20 |
| AST | U/L | 20 | 24.40 | 1.000 | 0.961 | 0.000 | -0.90 |
| ALT | U/L | 20 | 23.65 | 1.000 | 0.975 | 0.000 | -0.30 |
| HDL | mmol/L | 20 | 1.52 | 1.000 | 0.991 | -0.005 | 0.40 |
| Uric acid | umol/L | 20 | 290.40 | 1.018 | 0.994 | -5.041 | 0.20 |
| Potassium | mmol/L | 20 | 4.65 | 1.000 | 0.993 | 0.000 | 0.30 |
| Creatinine | umol/L | 20 | 80.65 | 0.947 | 0.908 | 4.289 | -1.10 |
| LDH | U/L | 20 | 148.85 | 1.000 | 0.997 | -0.500 | 0.00 |
| LDL Cholesterol | mmol/L | 20 | 2.93 | 0.988 | 0.995 | 0.025 | 0.20 |
| Lipase | U/L | 20 | 41.20 | 1.000 | 0.997 | -0.500 | 0.80 |
| Sodium | mmol/l | 20 | 138.80 | 1.000 | 0.830 | 0.000 | 0.22 |
| HDL Cholest. | mmol/l | 20 | 1.52 | 1.000 | 0.991 | -0.005 | 0.40 |
| Non - HDL Chol | mmol/l | 20 | 3.54 | 0.989 | 0.989 | 0.050 | -0.50 |
| Phosphate | mmol/l | 20 | 1.12 | 1.000 | 0.970 | -0.010 | 0.60 |
| Triglyceride | mmol/l | 20 | 1.51 | 1.000 | 0.994 | 0.000 | 0.30 |
| Vitamine B12 | pmol/L | 20 | 366.84 | 1.005 | 0.965 | -10.332 | 1.50 |
| TSH | mU/L | 20 | 2.04 | 1.000 | 0.998 | 0.010 | -0.70 |
| Bland-Altman | |||||||
| Analyte | Unit | n | Mean | Slope | r | Intercept | Arithmetic mean % |
| Hemoglobin | g/L | 20 | 139.35 | 1.000 | 0.994 | 1.000 | -0.70 |
| Hematocrit | % | 20 | 39.80 | 1.000 | 0.992 | 0.000 | -0.80 |
| Erythrocytes | x 10´`6/ul | 20 | 4.48 | 1.000 | 0.999 | 0.100 | -1.10 |
| RDW-CV | % | 20 | 13.15 | 1.000 | 0.987 | 0.000 | -0.07 |
| MCV | fl | 20 | 88.85 | 1.000 | 0.988 | 0.000 | -0.16 |
| MCH | pg | 20 | 31.30 | 1.000 | 0.860 | 0.000 | 0.50 |
| MCHC | g/L | 20 | 351.55 | 1.075 | 0.888 | -28.842 | 0.60 |
| PDW | fl | 20 | 12.39 | 1.158 | 0.899 | -2.092 | 0.10 |
| MPV | fl | 20 | 10.50 | 1.125 | 0.951 | -1.356 | 0.30 |
| Leukocytes | x 10´`3/ul | 20 | 6.80 | 1.014 | 0.983 | -0.089 | 0.50 |
| Eosinophils | % | 20 | 3.00 | 1.000 | 0.953 | -0.100 | 6.90 |
| Eosinophils | x 10´`3/ul | 20 | 0.19 | 1.000 | 0.977 | 0.000 | 0.00 |
| Basophils | % | 20 | 0.69 | 1.000 | 0.923 | 0.000 | -5.30 |
| Monocytes | % | 20 | 9.01 | 1.072 | 0.928 | -0.575 | -2.00 |
| Monocytes | x 10´`3/ul | 20 | 0.69 | 1.000 | 0.959 | 0.000 | 0.90 |
| Thrombocytes | x 10´`3/ul | 20 | 227.05 | 1.071 | 0.954 | -24.853 | 4.30 |
| Lymphocytes | % | 20 | 31.05 | 0.977 | 0.994 | 0.361 | 1.30 |
| Lymphocytes | x 10´`3/ul | 20 | 2.02 | 1.000 | 0.990 | -0.050 | 2.30 |
| Neutrophils | % | 20 | 56.26 | 0.960 | 0.997 | 2.663 | -1.10 |
| Bland-Altman | |||||||
| Analyte | Unit | n | Mean | Slope | r | Intercept | Arithmetic mean % |
| Quick | % | 20 | 111.20 | 1.000 | 0.926 | -1.500 | 1.50 |
| INR | 20 | 0.96 | 1.000 | 0.926 | 0.010 | 0.70 | |
| aPTT | s | 20 | 24.73 | 0.944 | 0.948 | 1.481 | -1.40 |
| Fibrinogen | g/L | 20 | 2.72 | 1.000 | 0.981 | -0.100 | 2.30 |
| D-Dimer | ug/L | 20 | 420.67 | 0.990 | 0.979 | 10.847 | -2.70 |
| Bland-Altman | |||||||
| Analyte | Unit | n | Mean | Slope | r | Intercept | Arithmetic mean % |
| Alk. Phos. | U/L | 20 | 64.38 | 1.000 | 0.997 | 1.000 | -0.50 |
| Billirubin total | umol/L | 20 | 8.32 | 1.000 | 0.974 | -0.500 | 0.50 |
| Calcium | mmol/L | 20 | 2.41 | 1.067 | 0.945 | -0.164 | 0.10 |
| Cholesterol | mmol/L | 20 | 5.01 | 1.000 | 0.995 | 0.000 | -0.20 |
| Creatine kinase | U/L | 20 | 157.35 | 1.000 | 0.996 | 0.000 | -0.50 |
| CRP | mg/L | 20 | 1.84 | 1.005 | 0.980 | 0.003 | -2.40 |
| Protein total | g/L | 20 | 74.47 | 1.000 | 0.984 | 0.000 | -0.10 |
| Ferritin | ng/mL | 20 | 134.61 | 1.008 | 0.991 | 0.538 | -1.60 |
| Folate | nmol/L | 20 | 20.23 | 1.077 | 0.964 | -1.346 | -0.80 |
| ƴGT | U/L | 20 | 23.23 | 1.000 | 0.993 | 0.000 | 1.00 |
| Glucose | mmol/L | 20 | 4.45 | 1.000 | 0.986 | 0.000 | 0.60 |
| AST | U/L | 20 | 24.81 | 1.000 | 0.958 | 1.000 | -2.40 |
| ALT | U/L | 20 | 26.77 | 1.000 | 0.993 | 0.000 | -0.50 |
| HDL | mmol/L | 20 | 1.68 | 1.000 | 0.997 | 0.000 | -0.20 |
| Uric acid | umol/L | 20 | 281.69 | 0.988 | 0.994 | 3.593 | 0.10 |
| Potassium | mmol/L | 20 | 3.87 | 1.000 | 0.964 | 0.000 | -0.40 |
| Creatinine | umol/L | 20 | 77.15 | 0.938 | 0.972 | 4.120 | 0.80 |
| LDH | U/L | 20 | 180.00 | 1.062 | 0.932 | -3.962 | -5.70 |
| LDL Cholesterol | mmol/L | 20 | 3.05 | 1.000 | 0.988 | 0.000 | 0.30 |
| Lipase | U/L | 20 | 38.26 | 1.000 | 0.993 | 0.000 | 0.20 |
| Sodium | mmol/l | 20 | 139.19 | 1.000 | 0.806 | 0.000 | 0.22 |
| Non - HDL Chol | mmol/l | 20 | 3.33 | 1.000 | 0.990 | 0.000 | -0.10 |
| Phosphate | mmol/l | 20 | 0.94 | 1.000 | 0.970 | 0.000 | -0.40 |
| Triglyceride | mmol/l | 20 | 1.07 | 1.000 | 0.996 | 0.000 | 0.30 |
| TSH | mU/L | 20 | 1.56 | 1.003 | 0.995 | -0.003 | 0.00 |
| Vitamine B12 | pmol/L | 20 | 358.23 | 1.026 | 0.985 | -12.053 | 0.70 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).